Használható Árva küszöbén tia aspirin Transcend egymás maró
NEJM on Twitter: "#VisualAbstract: In patients with minor ischemic stroke or TIA, aspirin + clopidogrel reduces risk of major ischemic events but increases risk of major hemorrhage at 90 days than aspirin
Efficacy of Clopidogrel-Aspirin Regimen for TIA and Minor Stroke | Download Table
Ischemic Benefit and Hemorrhage Risk of Ticagrelor-Aspirin Versus Aspirin in Patients With Acute Ischemic Stroke or Transient Ischemic Attack | Stroke
Medical therapies (Chapter 24) - Transient Ischemic Attack and Stroke
Antiplatelet Therapy for Secondary Stroke Prevention in Patients with Ischemic Stroke or Transient Ischemic Attack
Contraindications to aspirin in suspected TIA | Download Table
Immediate aspirin after mini-stroke substantially reduces risk of major stroke | University of Oxford
THALES: Ticagrelor Plus Aspirin Cuts Repeat Events After Stroke, TIA | tctmd.com
Antithrombotic therapies (Chapter 18) - The Stroke Book
THALES Secondary Efficacy | BRILINTA® (ticagrelor) tablets | For HCPs
Dual antiplatelet therapy with ticagrelor may increase the risk of all bleeding events in patients with minor strokes or high risk TIAs: a meta-analysis | Stroke and Vascular Neurology
A Comparison of Two Doses of Aspirin (30 mg vs. 283 mg a Day) in Patients after a Transient Ischemic Attack or Minor Ischemic Stroke | NEJM
Dual Antiplatelet Therapy Versus Aspirin in Patients With Stroke or Transient Ischemic Attack: Meta-Analysis of Randomized Controlled Trials | Stroke
Blogging Stroke – Role of Combined Clopidogrel and Aspirin in High-Risk TIA and Stroke: Discussing the POINT Trial
Stroke Guidelines | The International Aspirin Foundation
Current Recommendations for Secondary Stroke Prevention
Clopidogrel and Aspirin in Acute Ischemic Stroke and High‐Risk TIA | Semantic Scholar
Time Course for Benefit and Risk of Ticagrelor and Aspirin in Acute Ischemic Stroke or Transient Ischemic Attack | Neurology
Dual Antiplatelet Therapy Lowers Stroke, Death Rates in Ischemic Stroke/TIA Patients Better than Aspirin Alone - Physician's Weekly
Ticagrelor Added to Aspirin in Acute Nonsevere Ischemic Stroke or Transient Ischemic Attack of Atherosclerotic Origin | Stroke
Antithrombotic therapy by cause of TIA - UpToDate
Stroke Guidelines | The International Aspirin Foundation
Balancing Benefits and Risks of Long-Term Antiplatelet Therapy in Noncardioembolic Transient Ischemic Attack or Stroke | Stroke
The THALES Trial: Ticagrelor and Aspirin vs Aspirin Alone in Acute Ischemic Stroke or TIA - REBEL EM - Emergency Medicine Blog